Jung Un Shin

Associate | She/Her/Hers

Overview

Jung is an associate in Crowell & Moring’s Intellectual Property Group. Her practice focuses on helping clients secure strong patents across a wide range of technologies and provide strategic guidance on their intellectual property matters.

Jung’s experience includes drafting and prosecuting patent applications as well as conducting legal research on various intellectual property issues, including patents, trademarks, and copyright.  

During law school, Jung externed for Chief Justice Annette Kingsland Ziegler at the Wisconsin Supreme Court, gaining insights into the court litigation practices and procedures. Additionally, she also participated in the University’s Law and Entrepreneurship Clinic, advising startups on legal issues in business. Jung was also a finalist in the USPTO National Patent Application Drafting Competition.

Before law school, Jung worked as a Korean patent attorney at law firms in Seoul, gaining extensive experience in patent prosecution in the chemical and pharmaceutical fields, as well as invalidation trials and infringement litigations.

Career & Education

    • University of Wisconsin Law School, J.D., 2024
    • Korea Advanced Institute of Science and Technology, Master’s Degree, Intellectual Property, 2016
    • Hanyang University, B.S., cum laude, Chemistry, 2010
    • University of Wisconsin Law School, J.D., 2024
    • Korea Advanced Institute of Science and Technology, Master’s Degree, Intellectual Property, 2016
    • Hanyang University, B.S., cum laude, Chemistry, 2010
    • Illinois
    • U.S. Patent and Trademark Office (USPTO)
    • Korean Patent Attorney
    • Illinois
    • U.S. Patent and Trademark Office (USPTO)
    • Korean Patent Attorney
    • Korean Patent Attorneys Association
    • Illinois Bar Association
    • Korean Patent Attorneys Association
    • Illinois Bar Association
    • Korean
    • Korean

Jung's Insights

Client Alert | 3 min read | 07.21.25

Bypass Applications in U.S. Patent Practice: A Strategic Alternative to National Stage Entry

Applicants entering the U.S. national phase of an international (PCT) application have two options: enter the national stage under 35 U.S.C. §371 or file a “bypass” national application under 35 U.S.C. § 111(a). A bypass application allows applicants to file a new U.S. application that claims priority to the PCT application, treating the PCT application as a U.S. parent and bypassing the traditional national phase entry. Depending on the applicant’s goals and strategy, bypass applications can be filed as a continuation, divisional, or continuation-in-part (CIP)....

Jung's Insights

Client Alert | 3 min read | 07.21.25

Bypass Applications in U.S. Patent Practice: A Strategic Alternative to National Stage Entry

Applicants entering the U.S. national phase of an international (PCT) application have two options: enter the national stage under 35 U.S.C. §371 or file a “bypass” national application under 35 U.S.C. § 111(a). A bypass application allows applicants to file a new U.S. application that claims priority to the PCT application, treating the PCT application as a U.S. parent and bypassing the traditional national phase entry. Depending on the applicant’s goals and strategy, bypass applications can be filed as a continuation, divisional, or continuation-in-part (CIP)....